Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001790340-26-000014
Filing Date
2026-01-20
Accepted
2026-01-20 09:17:29
Documents
1
Period of Report
2026-01-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1768918646.html 4  
1 FORM 4 wk-form4_1768918646.xml 4 3454
  Complete submission text file 0001790340-26-000014.txt   4851
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address
Schall Thomas J. (Reporting) CIK: 0001423084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40675 | Film No.: 26541310

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Issuer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)